| 2026-08-24 | 8-K | Form 8-K, Item 5.02 |
| 2026-08-11 | 8-K | Form 8-K, Item 5.02 |
| 2026-08-06 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-08-05 | Deck | Q3 2026 Earnings Call Presentation |
| 2026-08-05 | Deck | Q3 2026 Earnings Call Presentation |
| 2026-08-04 | Press release | Azenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026 |
| 2026-08-04 | 8-K | Form 8-K, Item 2.02 results |
| 2026-07-08 | Press release | Azenta Completes Sale of B Medical Systems |
| 2026-07-08 | 8-K | Form 8-K, Item 1.01 |
| 2026-05-21 | ESG report | Investor document · FY 2025 · May 2026 |
| 2026-05-08 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-05-06 | Deck | Takes you to Presentation · Q2 2026 |
| 2026-05-05 | Press release | Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and |
| 2026-05-05 | Supplement | Takes you to Supplemental Information · Q2 2026 |
| 2026-05-05 | Press release | Takes you to Press Release · Q2 2026 |
| 2026-05-05 | 8-K | Form 8-K, Item 2.02 results |
| 2026-04-29 | Press release | Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast |
| 2026-04-29 | Press release | Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast |
| 2026-04-07 | Press release | Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution |
| 2026-04-07 | 8-K | Form 8-K, Item 5.02 |
| 2026-04-05 | ESG report | Investor document · FY 2026 · Apr 2026 |
| 2026-04-02 | 8-K | Form 8-K, Item 8.01 |
| 2026-03-10 | Deck | Investor presentation · Mar 2026 |
| 2026-03-04 | Press release | Press release · Mar 2026 |
| 2026-03-04 | Press release | Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities |
| 2026-03-04 | 8-K | Form 8-K, Item 1.01 |
| 2026-03-03 | Deck | Investor presentation · Q2 2026 · Mar 2026 |
| 2026-02-24 | Press release | Press release · Feb 2026 |
| 2026-02-24 | Press release | Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference |
| 2026-02-09 | Press release | Press release · Feb 2026 |
| 2026-02-09 | Press release | Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Inf |
| 2026-02-05 | 10-Q | Form 10-Q for the quarter ended Dec 31 |
| 2026-02-04 | Press release | Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025 |
| 2026-02-04 | Deck | Earnings presentation · Q1 2026 · Feb 2026 |
| 2026-02-04 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-02 | 8-K | Form 8-K, Item 5.02 |
| 2026-01-29 | 8-K | Form 8-K, Item 5.07 |
| 2026-01-21 | Press release | AZENTA ANNOUNCES FISCAL 2026 FIRST QUARTER CONFERENCE CALL AND WEBCAST |
| 2026-01-21 | Press release | Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast |
| 2025-12-29 | Press release | Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L |